Imatinib compared with second-generation tyrosine kinase inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase
In July 2023, a study led by Professor Qian Jiang from Peking University Institute of Hematology was published in the international academic journal ——American Journal of Hematology (IF=12.8). The title…
